Epicentre (an Illumina company)
Contact Us: 800-284-8474           Log In
 
Epicentre Forum 6 (2)

|Amplification of Human Papillomavirus (HPV) DNA From Gynecological Specimens Isolated Using MasterAmp™ DNA Extraction Solution and PreservCyt® Solution|

M. O'Connell, M. Cohenford, and B. Lentrichia, Cytyc Corporation, Boxborough, MA

Introduction

Anatomic molecular pathologists often rely on preserved tissue samples rather than cytological specimens to perform molecular assays on archived samples. This article describes a system that combines a method for collecting and preserving cytological samples with an easy-to-use technology for isolating PCR amplifiable products.

The ThinPrep® System (Cytyc Corp.) of sample collection and slide preparation is designed to improve the appearance and diagnostic accuracy of cytology slides. PreservCyt® Solution (Cytyc Corp.), used with the ThinPrep System, is a methanol-based collection medium that preserves the morphologic integrity of cervical cells during transportation and storage. PreservCyt Solution also preserves cellular proteins and nucleic acids within gynecological samples. Once the ThinPrep slide is made, remaining specimen can be used for further analysis such as Human Papillomavirus (HPV) testing. Applications such as in situ hybridization and immunocytochemistry have been previously performed on these types of samples,1-4 but procedures for extracting DNA from cells suspended in PreservCyt Solution for polymerase chain reaction (PCR) have not been well defined. Conventional methods for extracting DNA are often time-consuming and rely on the use of caustic reagents. Moreover, some of these procedures produce low yields of PCR-quality DNA.

Here, we describe a research application using the MasterAmp DNA Extraction Solution (Epicentre). The MasterAmp Solution was used to successfully purify HPV DNA from cervical cells collected into PreservCyt Solution yielding DNA free of PCR inhibitors, as demonstrated by amplification of a region of the HPV gene. Because the entire extraction reaction was performed in one tube, DNA yield was not compromised. beta-globin primers were used as internal controls to determine the integrity of the PCR reagents.5 Cell cultures positive and negative for HPV DNA were used as additional controls.

Materials and Methods

Samples

Residual exfoliated cervical cells collected into PreservCyt Solution and processed for the ThinPrep Processor were used in this study. Positive control (CaSki cells, 600 viral copies of HPV DNA/cell) and negative control (C-33A HPV negative cells) culture cell samples were collected and stored in PreservCyt Solution. All control samples were processed in an identical manner to the clinical samples as described below.

DNA extraction

DNA extraction was performed using the MasteAmp DNA Extraction Solution as follows: 1) 1-2 ml of PreservCyt sample was transferred to Eppendorf microcentrifuge tubes and centrifuged at 13,000 rpm for 5 minutes. The supernatants were removed and the cell pellets were resuspended in 500 µl of MasterAmp DNA Extraction Solution; 2) caps were screwed tightly and specimens were mixed by vortexing for 15 seconds. The tubes were then incubated at 60°C for 30 minutes; 3) the tubes were vortex mixed for 15 seconds and transferred to a 98°C waterbath for 8 minutes, mixed again, and transferred back to the 98°C waterbath for an additional 8 minutes. Then, the samples were mixed by vortexing and chilled on ice; 4) cellular debris was removed by centrifugation at 13,000 rpm for 5 minutes and supernatants containing purified DNA were transferred to a clean Eppendorf tube. DNA was stored at -20°C prior to analysis.

PCR amplification and detection

PCR conditions were as follows: 1.0 µM of each HPV primer (MY09/MY11, Research Genetics) and 0.1 µM of each ß-globin primer (GH20bg1/GH20bg2, Genosys Biotechnologies) were added to a reaction containing 2.5 units of GeneAmp AmpliTaq DNA Polymerase (Perkin Elmer), 200 µM of each dNTP (Perkin Elmer), 50 mM Tris-HCl (pH 8.0), 50 mM KCl, 5 mM MgCl2, and dH2O to a total volume of 50 µl. Lambda DNA and lambda primers were used as internal reagent controls following the same protocol as described above. The PCR conditions were 95°C for 4 minutes; followed by 35 cycles of 95°C for 1 minute, 55°C for 1 minute, and 72°C for 1 minute; followed by a final extension at 72°C for 10 minutes. PCR amplicons were detected by 1% agarose gel electrophoresis at 75 volts for 45 minutes. Bands were visualized under UV light using EtBr stain.

Results

As shown in Figure 1, the ß-globin gene was amplified from cervical cell or tissue culture cell DNA extracted using the MasterAmp DNA Extraction Solution (Lanes 3-6). HPV DNA could also be amplified from the virus-positive cell line CaSki (Lane 6), but was not amplified from the HPV negative cell line C-33A (Lane 5). Results also reveal the amplification of HPV DNA from HPV-positive cervical samples stored in PreservCyt Solution (Lane 4). As expected, no PCR product was obtained from the HPV-negative samples (Lane 3).

Figure 1. Representative PCR amplifications. PCR was performed as described in the text. Lane 1, dH2O negative control; Lane 2, lambda positive control; Lanes 3 & 4, cervical samples; Lane 5, HPV negative control cell line C-33A; Lane 6, HPV positive cell line CaSki.

Table 1 summarizes the results of the 30 cervical samples that were PCR amplified to detect the presence of both the ß-globin gene and HPV DNA. Thirty of 30 samples were positive for the ß-globin gene indicating that successful PCR amplification was achieved using DNA isolated with the MasterAmp DNA Extraction Solution.

Table 1. PCR Amplification Results

Primer Pair # of Patient Samples # of PCR + Samples
HPV 30 14
β - globin 0 30

Conclusions

The Epicentre MasterAmp DNA Extraction Solution was used to successfully isolate DNA from cervical cells collected into PreservCyt Solution. The HPV DNA also appeared to be free of any PCR inhibitors as it was readily amplified by Taq DNA polymerase indicating the suitability of MasterAmp DNA Extraction Solution for isolating PCR-ready DNA. Therefore, PCR amplification can be used as a research application tool for the detection of HPV DNA from cellular material in PreservCyt Solution.

References

  1. Kurtycz, D. et al. (1996) Diagnostic Cytopathology 15 (1), 46.
  2. Lentrichia, B. et al. (1994) 83rd Annual Meeting USCAP.
  3. Hampton, R.W. et al. (1996) Am. J. Pathol. 149, 1782.
  4. Ting, Y. and Manos, M.M. (1990) in: PCR Protocols: A Guide to Methods and Application, ed. Innis, M.A. et al., Academic Press, Inc., CA, 356.
  5. Bauer, H. et al. (1991) JAMA 265, 472.
  6. Saike, R. et al. (1985) Science 230, 1350.

HOME | PRODUCTS | WHAT'S NEW | TECHNICAL RESOURCES | ORDERING | COMPANY

Epicentre on Facebook  Epicentre on Twitter  Epicentre's Technical Blog   Epicentre® (an Illumina® company)
©2012 Epicentre. All Rights Reserved.